SCHEMBL13465083

SCHEMBL13465083

CC(C)C(C)CCC(F)(F)F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23516124 0.86
SCHEMBL18721603 0.82
SCHEMBL27374642 0.82
SCHEMBL16786183 0.82
SCHEMBL23776876 0.82
SCHEMBL16786184 0.82
SCHEMBL23394781 0.80
SCHEMBL23373102 0.78
SCHEMBL25589818 0.78
SCHEMBL19512703 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11860536-B2 Three-dimensional crosslinker composition and method of manufacturing electronic devices using the same UNIST (ULSAN NATIONAL INSTITUTE OF SCIENCE AND TECHNOLOGY) (KR) 2024-01-02 US disclosed
US-20200291018-A1 TAM KINASE INHIBITORS SYROS PHARMACEUTICALS, INC. (US) 2020-09-17 US disclosed
WO-2019014513-A1 TAM KINASE INHIBITORS SYROS PHARMACEUTICALS, INC. (US) 2019-01-17 WO disclosed
US-20120264711-A1 ANTIVIRAL COMPOUNDS GILEAD SCIENCES, INC. (US) 2012-10-18 US disclosed